AGÕæÈ˹ٷ½

STOCK TITAN

[Form 4] UNITEDHEALTH GROUP INCORPORATED (Delaware) Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Insider activity: On 24 Jun 2025, UnitedHealth Group (UNH) director and former CEO Stephen J. Hemsley reported the credit of 55 common shares at $0 cost, reflecting dividend-equivalent units paid on previously vested deferred stock units. These shares were immediately vested and subject to the same terms as the underlying units. Following the credit, Hemsley’s direct holdings rose to roughly 374,407.942 shares, alongside 347.29 shares held through a 401(k) plan and 735,115 shares held via family trusts. No derivative securities were exercised, and the filing does not reference a Rule 10b5-1 trading plan. The adjustment is routine, immaterial relative to Hemsley’s more than 1.1 million-share beneficial stake, and is unlikely to influence market perception or valuation.

Attività degli insider: Il 24 giugno 2025, Stephen J. Hemsley, direttore e ex CEO di UnitedHealth Group (UNH), ha riportato l'accredito di 55 azioni ordinarie a costo zero, corrispondenti a unità equivalenti a dividendi pagate su unità azionarie differite precedentemente maturate. Queste azioni sono state immediatamente maturate e soggette alle stesse condizioni delle unità sottostanti. Dopo l'accredito, le partecipazioni dirette di Hemsley sono salite a circa 374.407,942 azioni, a cui si aggiungono 347,29 azioni detenute tramite un piano 401(k) e 735.115 azioni detenute tramite trust familiari. Non sono stati esercitati titoli derivati e la comunicazione non fa riferimento a un piano di trading secondo la Regola 10b5-1. L'adeguamento è di routine, irrilevante rispetto alla partecipazione beneficiaria di oltre 1,1 milioni di azioni di Hemsley, e probabilmente non influenzerà la percezione del mercato o la valutazione.

Actividad de insiders: El 24 de junio de 2025, Stephen J. Hemsley, director y ex CEO de UnitedHealth Group (UNH), reportó el crédito de 55 acciones comunes sin costo, reflejando unidades equivalentes a dividendos pagadas sobre unidades de acciones diferidas previamente adquiridas. Estas acciones se consolidaron inmediatamente y están sujetas a los mismos términos que las unidades subyacentes. Tras el crédito, las participaciones directas de Hemsley aumentaron a aproximadamente 374,407.942 acciones, junto con 347.29 acciones mantenidas a través de un plan 401(k) y 735,115 acciones en fideicomisos familiares. No se ejercieron valores derivados y el informe no menciona un plan de negociación bajo la Regla 10b5-1. El ajuste es rutinario, insignificante en comparación con la participación beneficiaria de más de 1.1 millones de acciones de Hemsley, y probablemente no influirá en la percepción del mercado ni en la valoración.

ë‚´ë¶€ìž� 활ë™: 2025ë…� 6ì›� 24ì�, UnitedHealth Group(UNH)ì� ì´ì‚¬ì´ìž ì � CEOì� Stephen J. HemsleyëŠ� ì´ì „ì—� 확정ë� ì´ì—° ì£¼ì‹ ë‹¨ìœ„ì—� 대í•� ë°°ë‹¹ê¸ˆì— ìƒì‘하는 단위ë¡� 0ì›� 비용으로 55ì£� 보통주가 입금ë˜ì—ˆìŒì„ 보고했습니다. ì� 주ì‹ë“¤ì€ 즉시 확정ë˜ì—ˆìœ¼ë©° 기초 단위와 ë™ì¼í•� ì¡°ê±´ì� ì ìš©ë©ë‹ˆë‹�. 입금 í›� Hemsleyì� ì§ì ‘ 보유 주ì‹ì€ ì•� 374,407.942주로 ì¦ê°€í–ˆìœ¼ë©�, 401(k) 플랜ì� 통해 347.29ì£�, ê°€ì¡� ì‹ íƒì� 통해 735,115주를 보유하고 있습니다. íŒŒìƒ ì¦ê¶Œì€ 행사ë˜ì§€ 않았으며, 해당 보고서ì—ëŠ� 규칙 10b5-1 거래 계íšì� 언급ë˜ì–´ 있지 않습니다. ì� ì¡°ì •ì€ ì¼ìƒì ì´ê³�, Hemsleyì� 110ë§� ì£� ì´ìƒì� 실질 ì§€ë¶„ì— ë¹„í•´ 미미하며, 시장 ì¸ì‹ì´ë‚˜ í‰ê°€ì—� ì˜í–¥ì� 미칠 ê°€ëŠ¥ì„±ì€ ë‚®ìŠµë‹ˆë‹¤.

Activité des initiés : Le 24 juin 2025, Stephen J. Hemsley, directeur et ancien PDG de UnitedHealth Group (UNH), a déclaré le crédit de 55 actions ordinaires sans coût, correspondant à des unités équivalentes de dividendes versées sur des unités d'actions différées précédemment acquises. Ces actions ont été immédiatement acquises et sont soumises aux mêmes conditions que les unités sous-jacentes. Après ce crédit, les participations directes de Hemsley sont passées à environ 374 407,942 actions, auxquelles s'ajoutent 347,29 actions détenues via un plan 401(k) et 735 115 actions détenues par des trusts familiaux. Aucun titre dérivé n'a été exercé et le dépôt ne fait pas référence à un plan de négociation selon la règle 10b5-1. Cet ajustement est de routine, insignifiant par rapport à la participation bénéficiaire de plus de 1,1 million d'actions de Hemsley, et il est peu probable qu'il influence la perception du marché ou la valorisation.

±õ²Ô²õ¾±»å±ð°ù-´¡°ì³Ù¾±±¹¾±³Ùä³Ù±ð²Ô: Am 24. Juni 2025 meldete Stephen J. Hemsley, Direktor und ehemaliger CEO von UnitedHealth Group (UNH), die Gutschrift von 55 Stammaktien ohne Kosten, welche Dividenden-äquivalente Einheiten auf zuvor erworbene, gestundete Aktieneinheiten widerspiegeln. Diese Aktien wurden sofort freigegeben und unterliegen den gleichen Bedingungen wie die zugrunde liegenden Einheiten. Nach der Gutschrift stieg Hemsleys Direktbestand auf etwa 374.407,942 Aktien, zusätzlich zu 347,29 Aktien, die über einen 401(k)-Plan gehalten werden, und 735.115 Aktien, die über Familienstiftungen gehalten werden. Es wurden keine Derivate ausgeübt, und die Meldung verweist nicht auf einen Handelsplan gemäß Regel 10b5-1. Die Anpassung ist routinemäßig, im Vergleich zu Hemsleys mehr als 1,1 Millionen Aktien umfassendem wirtschaftlichem Interesse unerheblich und wird wahrscheinlich die Marktmeinung oder Bewertung nicht beeinflussen.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Routine dividend credit; negligible size; neutral impact.

The 55-share addition equals less than 0.005 % of Hemsley’s total beneficial ownership and involved no cash transaction, indicating a standard administrative adjustment rather than an intentional insider purchase. Such filings rarely affect trading dynamics or signal sentiment change. There are no derivative moves, and beneficial ownership remains above 1.1 million shares. Market implication: neutral.

TL;DR: Clean Section 16 compliance; no governance concerns.

The Form 4 is timely and properly executed, showing dividend-equivalent units credited under an existing compensation plan. No errors, backdating, or 10b5-1 notations appear, and the attorney-in-fact signature is standard. From a governance lens, the filing is routine and poses no red flags or material considerations for shareholders.

Attività degli insider: Il 24 giugno 2025, Stephen J. Hemsley, direttore e ex CEO di UnitedHealth Group (UNH), ha riportato l'accredito di 55 azioni ordinarie a costo zero, corrispondenti a unità equivalenti a dividendi pagate su unità azionarie differite precedentemente maturate. Queste azioni sono state immediatamente maturate e soggette alle stesse condizioni delle unità sottostanti. Dopo l'accredito, le partecipazioni dirette di Hemsley sono salite a circa 374.407,942 azioni, a cui si aggiungono 347,29 azioni detenute tramite un piano 401(k) e 735.115 azioni detenute tramite trust familiari. Non sono stati esercitati titoli derivati e la comunicazione non fa riferimento a un piano di trading secondo la Regola 10b5-1. L'adeguamento è di routine, irrilevante rispetto alla partecipazione beneficiaria di oltre 1,1 milioni di azioni di Hemsley, e probabilmente non influenzerà la percezione del mercato o la valutazione.

Actividad de insiders: El 24 de junio de 2025, Stephen J. Hemsley, director y ex CEO de UnitedHealth Group (UNH), reportó el crédito de 55 acciones comunes sin costo, reflejando unidades equivalentes a dividendos pagadas sobre unidades de acciones diferidas previamente adquiridas. Estas acciones se consolidaron inmediatamente y están sujetas a los mismos términos que las unidades subyacentes. Tras el crédito, las participaciones directas de Hemsley aumentaron a aproximadamente 374,407.942 acciones, junto con 347.29 acciones mantenidas a través de un plan 401(k) y 735,115 acciones en fideicomisos familiares. No se ejercieron valores derivados y el informe no menciona un plan de negociación bajo la Regla 10b5-1. El ajuste es rutinario, insignificante en comparación con la participación beneficiaria de más de 1.1 millones de acciones de Hemsley, y probablemente no influirá en la percepción del mercado ni en la valoración.

ë‚´ë¶€ìž� 활ë™: 2025ë…� 6ì›� 24ì�, UnitedHealth Group(UNH)ì� ì´ì‚¬ì´ìž ì � CEOì� Stephen J. HemsleyëŠ� ì´ì „ì—� 확정ë� ì´ì—° ì£¼ì‹ ë‹¨ìœ„ì—� 대í•� ë°°ë‹¹ê¸ˆì— ìƒì‘하는 단위ë¡� 0ì›� 비용으로 55ì£� 보통주가 입금ë˜ì—ˆìŒì„ 보고했습니다. ì� 주ì‹ë“¤ì€ 즉시 확정ë˜ì—ˆìœ¼ë©° 기초 단위와 ë™ì¼í•� ì¡°ê±´ì� ì ìš©ë©ë‹ˆë‹�. 입금 í›� Hemsleyì� ì§ì ‘ 보유 주ì‹ì€ ì•� 374,407.942주로 ì¦ê°€í–ˆìœ¼ë©�, 401(k) 플랜ì� 통해 347.29ì£�, ê°€ì¡� ì‹ íƒì� 통해 735,115주를 보유하고 있습니다. íŒŒìƒ ì¦ê¶Œì€ 행사ë˜ì§€ 않았으며, 해당 보고서ì—ëŠ� 규칙 10b5-1 거래 계íšì� 언급ë˜ì–´ 있지 않습니다. ì� ì¡°ì •ì€ ì¼ìƒì ì´ê³�, Hemsleyì� 110ë§� ì£� ì´ìƒì� 실질 ì§€ë¶„ì— ë¹„í•´ 미미하며, 시장 ì¸ì‹ì´ë‚˜ í‰ê°€ì—� ì˜í–¥ì� 미칠 ê°€ëŠ¥ì„±ì€ ë‚®ìŠµë‹ˆë‹¤.

Activité des initiés : Le 24 juin 2025, Stephen J. Hemsley, directeur et ancien PDG de UnitedHealth Group (UNH), a déclaré le crédit de 55 actions ordinaires sans coût, correspondant à des unités équivalentes de dividendes versées sur des unités d'actions différées précédemment acquises. Ces actions ont été immédiatement acquises et sont soumises aux mêmes conditions que les unités sous-jacentes. Après ce crédit, les participations directes de Hemsley sont passées à environ 374 407,942 actions, auxquelles s'ajoutent 347,29 actions détenues via un plan 401(k) et 735 115 actions détenues par des trusts familiaux. Aucun titre dérivé n'a été exercé et le dépôt ne fait pas référence à un plan de négociation selon la règle 10b5-1. Cet ajustement est de routine, insignifiant par rapport à la participation bénéficiaire de plus de 1,1 million d'actions de Hemsley, et il est peu probable qu'il influence la perception du marché ou la valorisation.

±õ²Ô²õ¾±»å±ð°ù-´¡°ì³Ù¾±±¹¾±³Ùä³Ù±ð²Ô: Am 24. Juni 2025 meldete Stephen J. Hemsley, Direktor und ehemaliger CEO von UnitedHealth Group (UNH), die Gutschrift von 55 Stammaktien ohne Kosten, welche Dividenden-äquivalente Einheiten auf zuvor erworbene, gestundete Aktieneinheiten widerspiegeln. Diese Aktien wurden sofort freigegeben und unterliegen den gleichen Bedingungen wie die zugrunde liegenden Einheiten. Nach der Gutschrift stieg Hemsleys Direktbestand auf etwa 374.407,942 Aktien, zusätzlich zu 347,29 Aktien, die über einen 401(k)-Plan gehalten werden, und 735.115 Aktien, die über Familienstiftungen gehalten werden. Es wurden keine Derivate ausgeübt, und die Meldung verweist nicht auf einen Handelsplan gemäß Regel 10b5-1. Die Anpassung ist routinemäßig, im Vergleich zu Hemsleys mehr als 1,1 Millionen Aktien umfassendem wirtschaftlichem Interesse unerheblich und wird wahrscheinlich die Marktmeinung oder Bewertung nicht beeinflussen.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
HEMSLEY STEPHEN J

(Last) (First) (Middle)
C/O UNITEDHEALTH GROUP INCORPORATED
1 HEALTH DRIVE

(Street)
EDEN PRAIRIE MN 55344

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
UNITEDHEALTH GROUP INC [ UNH ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
CEO, UHG
3. Date of Earliest Transaction (Month/Day/Year)
06/24/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 06/24/2025 A 55(1) A $0 374,407.942 D
Common Stock 347.29 I By 401(k)
Common Stock 735,115 I By Trusts
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents dividend equivalents paid on vested deferred stock units. The dividend equivalents are immediately vested and are subject to the same terms as the underlying deferred stock units.
Remarks:
Faraz A. Choudhry, Attorney-in-Fact for Stephen J. Hemsley 06/26/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many UNH shares did Stephen Hemsley acquire on 24 June 2025?

He received 55 common shares credited as dividend-equivalent units.

What is Hemsley’s total direct UNH ownership after the transaction?

His direct stake is approximately 374,407.942 shares.

Did Stephen Hemsley pay cash for the reported shares?

No; the shares were issued at $0 cost as dividend equivalents.

Were any derivative securities exercised in this filing?

No; Table II shows no derivative transactions.

Does the Form 4 reference a Rule 10b5-1 trading plan?

The filing does not indicate execution under a 10b5-1 plan.

When was the Form 4 signed and filed?

The document was signed on 26 June 2025 and reflects a transaction dated 24 June 2025.
Unitedhealth Gp

NYSE:UNH

UNH Rankings

UNH Latest News

UNH Latest SEC Filings

UNH Stock Data

246.17B
904.48M
0.27%
90.58%
1.4%
Healthcare Plans
Hospital & Medical Service Plans
United States
EDEN PRAIRIE